Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study
2012 ◽
Vol 66
(5)
◽
pp. e180-e182
◽
2006 ◽
Vol 30
(6)
◽
pp. 1159-1162
◽
2014 ◽
Vol 20
(3)
◽
pp. 495-501
◽